Ketamine Adverse Reaction, Pain, Postoperative Pain
Conditions
Brief summary
Observational study that evaluate the cardiovascular and neuropsychiatric side effects of ketamine analgesic infusions for acute pain
Detailed description
Severe acute pain and opioid tolerance is an important symptom in patients after surgery. Ketamine in analgesic infusion has been described to decrease acute pain, in patients with opioid tolerance. Ketamine use has been associated with side effects, which are doses dependant. Those side effects are mainly cardiovascular: Hypertension, tachycardia, and neuropsychiatric: delirium, hallucinations,nightmares that potentially compromise recovery of patients. Objective: To determine retrospectively in data bases the frequency of tachycardia, hypertension, delirium, hallucinations and nightmares, in adult patients that received ketamine infusions before and after administration of this drug in the first 48 hours to treat acute and postoperative pain
Interventions
DRUGKetamine
Drug: Ketamine Side effects associated with ketamine infusion to treat acute pain, were reviewed after 48 hours of exposure and frequency of tachycardia, hypertension, hallucinations, delirium and nightmares were registrated for comparison
Sponsors
Universidad de Antioquia
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients older than 18 years old * Acute and Postoperative pain * Ketamine infusion at 0.15 mg/kg/h or below
Exclusion criteria
* Cognitive disfunction psychiatric illness * Acute cardiovascular disease * Anemia with Hb less than 7 g/dl * Decompensated hyperthyroidism * Low cardiac output * Incomplete medical history
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Tachycardia | 2 days | Presence of absence of tachycardia (100 or above beats for minute) as physiological parameter recorded with cardioscope in the first 48 hours in clinical chart database after the infusion of ketamine has started. |
| Hypertension | 2 days | Presence or absence of hypertension (140/90 mm Hg or above ) as physiological parameter recorded with electronic arm manometer in the first 48 hours in clinical chart database after the infusion of ketamine has started. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Delirium | 2 days | Presence of absence of delirium reported in clinical records electronic database by nurse or physician in the first 48 hours after the infusion of ketamine has started. |
| Hallucinations | 2 days | Presence of absence hallucinations reported in clinical electronic database records by nurse or physician in the first 48 hours after the infusion of ketamine has started. |
| Nightmares | 2 days | Presence of absence of nightmares reported in clinical electronic database records by nurse or physician, in the first 48 hours after the infusion of ketamine has started. |
Countries
Colombia
Outcome results
None listed